Skip to main content

Table 1 Baseline characteristics of demographic, clinical and laboratory data

From: Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective study

variables

 

Age in years, mean ± SD

31.7 ± 6.6

Male, %

85.1%

HBV genotype C, %

100%

Baseline ALT, IU/L

216.3 ± 169.7

Baseline HBV DNA(log10copies/ml)

8.5 ± 0.8

Baseline HBeAg(log10)

2.8 ± 0.4

BaselineHBsAg(log10)

3.7 ± 0.5